NYU's Dr Holly Lofton says some patients using gray-market reta saw no weight loss, and both experts warn against buying it online while it remains unapproved in the UK.
Recap by typeshit. Full story at Women's Health.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
Novo Nordisk's newest Wegovy injection puts fresh pressure on rivals in the race to lead obesity treatment, The Times reports.
NPR counted over 1,000 FDA reports of optic neuropathy tied to GLP-1s since 2024. Novo Nordisk calls the claims meritless and Lilly says it will fight them.
Loading…